Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms

Oncogene

Volumn 13, Issue 6, 1996, Pages 1359-1365

  Yu, Dihua ^a,b   Liu, Bolin ^a   Tan, Ming ^a   Li, Junzhi ^a   Wang, Shan Shue ^a   Hung, Mien Chie ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; c erbB 2 HER 2; Drug resistance; Oncogene; Taxol

Indexed keywords

GENE PRODUCT; GLYCOPROTEIN P; PACLITAXEL; THIORIDAZINE;

ARTICLE; BREAST TUMOR; CANCER CELL; CELL CYCLE S PHASE; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE C ERB; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; P-GLYCOPROTEIN; PACLITAXEL; RECEPTOR, ERBB-2; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029830451     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Akiyama T, Sudo C, Ogawara H, Toyoshima K and Yamamoto T. (1986). Science, 232, 1644-1646.
2. Arteaga CL, Winnier AR, Poirier MC, Lopez-Larraza DM, Shawver LK, Hurd SD and Stewart SJ. (1994). Cancer Res., 54, 3758-3765.
3. Bargmann CI, Hung M-C and Weinberg RA. (1986). Nature, 319, 226-230.
4. Chevalier B, Fumoleau P, Kerbrat P, Dieras V, Roche H, Krakowski I, Azli N, Bayssas M, Lentz MA and Van Glabbeke M. (1995). J. of Clin. Oncol., 13, 314-322.
5. Coussens L, Yang-Feng TL, Liao Y-C, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A and Ullrich A. (1985). Science, 230, 1132-1139.
6. Cree IA, Pazzagli M, Mini E, Mazzei T, Hunter EM, Sutherland LA, Pinzani P, Gerli A and Andreotti PE. (1995). Anti-Cancer Drugs, 6, 398-404.
7. Efferth T and Volm M. (1993). Cancer Lett., 70, 197-202.
8. Gusterson BA, Gelber RD, Goldhirsch A, Price KN, Save-Soderborgh J, Anbazhagan R, Styles J, Rudenstam C-M, Golouh R, Reed R, Martinez-Tello F, Tiltman A, Torhorst J, Grigolato P, Bettelheim R, Neville AM, Burki K, Castiglione M, Collins J, Lindtner J, Senn H-J and Ludwig IBCSG. (1992). J. Clin. Oncol., 10, 1049-1056.
9. Hancock MC, Langton BC, Chan T, Toy P, Monahan JJ, Mischak RP and Shawver LK. (1991). Cancer Res., 51, 4575-4580.
10. Harris JR, Lippman ME, Veronesi U and Willett W. (1992). N. Engl. J. Med., 327, 319-328, 390-398, 473-480.
11. Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK and Hortobagyi GN. (1991). J. Natl. Cancer Inst., 83, 1797-1805.
12. Hudziak RM, Schlessinger J and Ullrich A. (1987). Proc. Natl. Acad. Sci. USA, 84, 7159-7163.
13. Hung M. (1988). Cancer Bull., 40, 300-303.
14. Kraus MH, Popescu NC, Amsbaugh SC and King CR. (1987). EMBO J., 6, 605-610.
15. Kuo MT, Vyas RC, Jiang L-X and Hittleman WN. (1994). Mol. Cell. Biol., 14, 5202-5211.
16. Lacroix H, Iglehart JD, Skinner MA and Kraus MH. (1989). Oncogene, 4, 145-151.
17. Moscow JA and Cowan KH. (1988). J. Natl. Cancer Inst., 80, 14-20.
18. Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koerner F, Cirrincione CT, Budman DR, Wood WC, Barcos M and Henderson IC. (1994). N. Engl. J. Med., 330, 1260-1266.
19. Niimi S, Nakagawa K, Yokota J, Tsunokawa Y, Nishio K, Terashima Y, Shibuya M, Terada M and Saijo N. (1991). Br. J. Cancer, 63, 237-241.
20. Nooter K and Herweijer H. (1991). Br. J. Cancer, 63, 663.
21. Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB and Slamon DJ. (1994). Oncogene, 9, 1829-1838.
22. Promega. (1991). Technical Bulletin, Promega Corp. Madison, WI: Promega Corp., 169,.
23. Schneider J, Rubio M-P, Barbazan M-J, Rodriguez-Escudero FJ, Seizinger BR and Castresana JS. (1994). J. Natl. Cancer Inst., 86, 850-854.
24. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
25. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and McGuire WL. (1989). Science, 244, 707-712.
26. Stern DF, Heffernan PA and Weinberg RA. (1986). Mol. Cell. Biol., 6, 1729-1740.
27. Tauchi K, Hori S, Itoh H, Osamura RY, Tokuda Y and Tajima T. (1989). Virchows Arch. A Pathol. Anat. Histopathol., 416, 65-73.
28. Tsai C-M, Chang K-T, Perng R-P, Mitsudomi T, Chen M-H, Kadoyama C and Gazdar AF. (1993). J. Natl. Cancer Inst., 85, 897-901.
29. Tsai C-M, Yu D, Chang K-T, Wu L-H, Perng PR-P, Ibrahim NK and Hung M-C. (1995). J. Natl. Cancer Inst., 87, 682-684.
30. Tsai CM, Chang KT, Wu LH, Chen JY, Gazdar AFTM, Chen MH and Perng RP. (1996). Cancer Res., 56, 206-209.
31. Wall ME and Wani MC. (1995). Cancer Res., 55, 753-760.
32. Wani MC, Taylor HL, Wall ME, Coggon P and McPhail AT. (1971). J. Am. Chem. Soc., 93, 2325-2327.
33. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T and Toyoshima K. (1986). Nature, 319, 230-234.
34. Yu D and Hung MC. (1991). Oncogene, 6, 1991-1996.
35. Yu D, Wang S-S, Dulski KM, Tsai C-M, Nicolson GL and Hung M-C. (1994). Cancer Res., 54, 3260-3266.